Heidi Murray‐Smith

1.4k total citations
25 papers, 443 citations indexed

About

Heidi Murray‐Smith is a scholar working on Psychiatry and Mental health, Physiology and Infectious Diseases. According to data from OpenAlex, Heidi Murray‐Smith has authored 25 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 8 papers in Physiology and 4 papers in Infectious Diseases. Recurrent topics in Heidi Murray‐Smith's work include Dementia and Cognitive Impairment Research (12 papers), Alzheimer's disease research and treatments (7 papers) and Antifungal resistance and susceptibility (4 papers). Heidi Murray‐Smith is often cited by papers focused on Dementia and Cognitive Impairment Research (12 papers), Alzheimer's disease research and treatments (7 papers) and Antifungal resistance and susceptibility (4 papers). Heidi Murray‐Smith collaborates with scholars based in United Kingdom, United States and France. Heidi Murray‐Smith's co-authors include John Bacher, Vidmantas Petraitis, Thomas J. Walsh, Amy M. Kelaher, Rūta Petraitienė, Tin Sein, Nick C. Fox, Jonathan M. Schott, Thomas D. Parker and Sarah E Keuss and has published in prestigious journals such as PLoS ONE, NeuroImage and Brain.

In The Last Decade

Heidi Murray‐Smith

23 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heidi Murray‐Smith United Kingdom 12 169 159 126 109 91 25 443
Yukihiko Fujita Japan 13 160 0.9× 49 0.3× 129 1.0× 101 0.9× 47 0.5× 60 620
Bernadette Sullivan United States 12 147 0.9× 174 1.1× 63 0.5× 86 0.8× 159 1.7× 15 1.2k
Mianwang He China 13 50 0.3× 99 0.6× 512 4.1× 55 0.5× 119 1.3× 32 760
Talia R. Seider United States 9 112 0.7× 58 0.4× 65 0.5× 140 1.3× 44 0.5× 11 524
Yohannes W. Woldeamanuel United States 17 63 0.4× 88 0.6× 568 4.5× 48 0.4× 173 1.9× 43 965
Robert A. Velin United States 8 384 2.3× 99 0.6× 148 1.2× 95 0.9× 66 0.7× 9 922
T Takasu Japan 13 92 0.5× 99 0.6× 35 0.3× 78 0.7× 70 0.8× 51 544
Andrea Hoppe Germany 11 97 0.6× 170 1.1× 443 3.5× 519 4.8× 88 1.0× 15 1.5k
Sandra Suárez France 13 106 0.6× 48 0.3× 40 0.3× 41 0.4× 58 0.6× 22 558
Håkon Hofstad Norway 15 61 0.4× 122 0.8× 133 1.1× 38 0.3× 13 0.1× 30 554

Countries citing papers authored by Heidi Murray‐Smith

Since Specialization
Citations

This map shows the geographic impact of Heidi Murray‐Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi Murray‐Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi Murray‐Smith more than expected).

Fields of papers citing papers by Heidi Murray‐Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidi Murray‐Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi Murray‐Smith. The network helps show where Heidi Murray‐Smith may publish in the future.

Co-authorship network of co-authors of Heidi Murray‐Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Heidi Murray‐Smith. A scholar is included among the top collaborators of Heidi Murray‐Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi Murray‐Smith. Heidi Murray‐Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brown, Thomas H., Sarah‐Naomi James, Jennifer M. Nicholas, et al.. (2025). Association of Increase in White Matter Hyperintensity Volume With Rate of Hippocampal Atrophy in a Population-Based Study of Aging. Neurology. 105(5). e213975–e213975.
2.
Giunchiglia, Valentina, Maria Popham, Andrew Wong, et al.. (2025). Online46: Online cognitive assessments in elderly cohorts—The British 1946 birth cohort case study. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 17(2). e70098–e70098. 1 indexed citations
3.
James, Sarah‐Naomi, Carole H. Sudre, Josephine Barnes, et al.. (2024). The relationship between leisure time physical activity patterns, Alzheimer’s disease markers and cognition. Brain Communications. 7(1). fcae431–fcae431. 3 indexed citations
4.
Lu, Kirsty, John Baker, Jennifer M. Nicholas, et al.. (2024). Associations between accelerated forgetting, amyloid deposition and brain atrophy in older adults. Brain. 148(4). 1302–1315. 3 indexed citations
5.
6.
Jones, Siana, Sarah‐Naomi James, Heidi Murray‐Smith, et al.. (2022). Association between carotid atherosclerosis and brain activation patterns during the Stroop task in older adults: An fNIRS investigation. NeuroImage. 257. 119302–119302. 8 indexed citations
7.
Pavisic, Ivanna M., Kirsty Lu, Sarah E Keuss, et al.. (2021). Subjective cognitive complaints at age 70: associations with amyloid and mental health. Journal of Neurology Neurosurgery & Psychiatry. 92(11). 1215–1221. 24 indexed citations
8.
Keshavan, Ashvini, Henrietta Wellington, Zhongbo Chen, et al.. (2021). Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 13(1). e12131–e12131. 31 indexed citations
9.
Buchanan, Sarah M., Thomas D. Parker, Chris Lane, et al.. (2020). Olfactory testing does not predict β-amyloid, MRI measures of neurodegeneration or vascular pathology in the British 1946 birth cohort. Journal of Neurology. 267(11). 3329–3336. 5 indexed citations
10.
Jones, Siana, Gemma Bale, Sarah‐Naomi James, et al.. (2020). Study Protocol — Insight 46 Cardiovascular: A Sub-study of the MRC National Survey of Health and Development. Artery Research. 26(3). 170–179. 1 indexed citations
11.
James, Sarah‐Naomi, Christopher Lane, Ashvini Keshavan, et al.. (2020). Lifetime cigarette smoking and later‐life brain health: The population‐based 1946 British Birth Cohort. Alzheimer s & Dementia. 16(S10). 1 indexed citations
12.
Keshavan, Ashvini, Henrietta Wellington, Zhongbo Chen, et al.. (2020). Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 12(1). e12097–e12097. 14 indexed citations
13.
Keuss, Sarah E, Thomas D. Parker, Christopher Lane, et al.. (2019). Incidental findings on brain imaging and blood tests: results from the first phase of Insight 46, a prospective observational substudy of the 1946 British birth cohort. BMJ Open. 9(7). e029502–e029502. 10 indexed citations
14.
Parker, Thomas D., David M. Cash, Chris Lane, et al.. (2019). Pure tone audiometry and cerebral pathology in healthy older adults. Journal of Neurology Neurosurgery & Psychiatry. 91(2). 172–176. 20 indexed citations
15.
Parker, Thomas D., David M. Cash, Christopher Lane, et al.. (2019). Hippocampal subfield volumes and pre-clinical Alzheimer’s disease in 408 cognitively normal adults born in 1946. PLoS ONE. 14(10). e0224030–e0224030. 24 indexed citations
16.
Lu, Kirsty, Jennifer M. Nicholas, Jessica Collins, et al.. (2019). Cognition at age 70. Neurology. 93(23). e2144–e2156. 30 indexed citations
17.
James, Sarah‐Naomi, Christopher Lane, Thomas D. Parker, et al.. (2018). Using a birth cohort to study brain health and preclinical dementia: recruitment and participation rates in Insight 46. BMC Research Notes. 11(1). 885–885. 30 indexed citations
18.
Duchaine, Bradley, Heidi Murray‐Smith, Martha Turner, Sarah White, & Lúcia Garrido. (2009). Normal social cognition in developmental prosopagnosia. Cognitive Neuropsychology. 26(7). 620–634. 39 indexed citations
19.
Petraitienė, Rūta, Vidmantas Petraitis, William Hope, et al.. (2008). (1→3)-β-D-Glucan in Cereobrospinal Fluid is a Surrogate Marker for Detection and Therapeutic Response of Hematogenous Candida Meningoencephalitis. International Journal of Infectious Diseases. 12. S48–S49. 1 indexed citations
20.
Petraitienė, Rūta, Vidmantas Petraitis, William Hope, et al.. (2008). Cerebrospinal Fluid and Plasma (1→3)-β-d-Glucan as Surrogate Markers for Detection and Monitoring of Therapeutic Response in Experimental HematogenousCandidaMeningoencephalitis. Antimicrobial Agents and Chemotherapy. 52(11). 4121–4129. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yukihiko Fujita Breakdown of academic impact, for papers by Bernadette Sullivan Breakdown of academic impact, for papers by Mianwang He Breakdown of academic impact, for papers by Talia R. Seider Breakdown of academic impact, for papers by Yohannes W. Woldeamanuel Breakdown of academic impact, for papers by Robert A. Velin Breakdown of academic impact, for papers by T Takasu Breakdown of academic impact, for papers by Andrea Hoppe Breakdown of academic impact, for papers by Sandra Suárez Breakdown of academic impact, for papers by Håkon Hofstad
Rankless by CCL
2026